Structure via PubChem · Public domain (PubChem)
metharbital
Sign in to saveAlso known as Gemonil®, Metharbitalum, Metarbital
Metharbital was patented in 1905 by Emil Fischer working for Merck. It was marketed as Gemonil by Abbott Laboratories. It is a barbiturate anticonvulsant, used in the treatment of epilepsy. It has similar properties to phenobarbital.
Chemical data
- Formula
- C9H14N2O3
- Molecular weight
- 198.22 g/mol
- IUPAC name
- 5,5-diethyl-1-methyl-1,3-diazinane-2,4,6-trione
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 1982
- Admin. routes
- oral
- Indications
- epilepsy
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 198.100442
- Has use
- medication
Show 5 more facts
- chemical formula
- C₉H₁₄N₂O₃
- World Health Organisation international non-proprietary name
- metharbital
- canonical SMILES
- CCC1(C(=O)NC(=O)N(C1=O)C)CC
- defined daily dose
- 0.2
- Commons category
- Metharbital
via Wikidata · CC0
~1 min read
Encyclopedic overview
3 sectionsContents
- History
- Synthesis
- References
Metharbital was patented in 1905 by Emil Fischer working for Merck. It was marketed as Gemonil by Abbott Laboratories. It is a barbiturate anticonvulsant, used in the treatment of epilepsy. It has similar properties to phenobarbital.
== History == 1952 Gemonil was introduced by Abbott Laboratories. 1990 Abbott stopped marketing.
Excerpted from Wikipedia’s “metharbital” article, available under the CC BY-SA 4.0 licence.
Available in 10 languages
via Wikidata sitelinks · CC0